Tikomed Has Received Permission to Carry Out a Study of Their Experimental Drug for ALS in the UK
The speciality pharmaceutical company Tikomed has announced that the UK Medicines and Healthcare Products Regulatory Agency has granted the company permission to go ahead with a Phase 2 clinical study.…